Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.

<h4>Background</h4>Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methyl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ibrahim Musa Yola, Carlee Moser, Meredith S Duncan, Edzard Schwedhelm, Dorothee Atzler, Renke Maas, Juliane Hannemann, Rainer H Böger, Ramachandran S Vasan, Vanessa Xanthakis
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ceb4479eea9640919734a6f24a35e397
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!